Antibiotic-resistant bacteria have become a global concern and new strategies to control pathogenic bacteria are urgently needed. Toxin antitoxin (TA) system is defined as a regulator system consist of toxin that neutralized by cognate antitoxin. In theory, activation of the toxin or inhibition of the antitoxin within a bacterial TA system could provide a potent new antibiotic therapy. TA systems can increase pathogen stress tolerance and certain TA loci have be characterized in a small number of Methicillin Resistant Staphylococcus aureus (MRSA), Vancomycin Resistant Enterococcus (VRE), E. coli, and Pesudomanas aeruginosa. Here it is determined the prevalence of TA system in a large number of independently isolated clinical isolates of antibiotic resistant S. aureus from diverse locations, then functionality of dominant TA system is evaluated and the antitoxin is subjected for silencing by antiMazE Peptide Nucleotide Acid (PNA) subsequently the suicide of bacteria by toxin is determined. To evaluate potential TA loci as therapeutic targets, it was screened the plasmid and chromosome sequences of 1000 clinical isolates of S. aureus from Milad hospital in Iran and 60 MRSA clinical isolates from Hospital Kuala Lumpur (HKL) in Malaysia for the presence of TA loci. Plasmid-borne MazEF TA loci were present in all tested, antibiotic resistant S. aureus strains in Iran and MRSA in Malaysia while when DNA were subjected as template, 21.2% of Milad hospital and 22.6% of HKL isolates were positive for MazEF TA system. In addition, plasmid transformation confirmed MazEF TA loci harboured on plasmid. Additionally, RT-PCR analysis revealed that the transcripts were produced from MazEF TA loci, suggesting that these loci are functional in the clinical isolates. Toxin transcript expression levels were increase when bacteria were grown under stressful conditions. Furthermore, cellular ATP levels are decreased consistent with MazF toxin expression and activity. 
Introduction
The decade of the 1940s witnessed the introduction of penicillin, the first antimicrobial agent that was effective against Staphylococcus aureus (Kirby, 1944) . Subsequently, resistance to penicillin was observed (Demerec, 1945) and during the two decades following the 1940s, penicillin resistant S. aureus became a worldwide concern (Rountree et al., 1954) . In 1959, methicillin was used for treatment of infections arising from penicillin resistant S. aureus. However, in 1961, the first Methicillin Resistant Staphylococcus aureus (MRSA) was reported (Jevons, 1961) . Toxin-antitoxin (TA) systems, which were first described in the mid 1980s, are regulatory loci that encode a toxin and its corresponding antitoxin. The toxin and antitoxin may be an RNA or protein, but in all TA systems reported to date, the antitoxin is unstable, and the toxin is stable. TA loci appear to be more common in pathogenic bacteria, but many plasmids contain TA loci. One role of TA loci is to stabilize plasmids within cells, but they also play a role in stress resistance (Aizenman et al., 1996) . Plasmid stability is conferred by TA elements; at the time of cell division, all daughter cells will inherit stable toxin molecules or toxinencoding mRNA, but only those cells that inherit plasmid DNA will be able to replenish sufficient antitoxin to survive. This process is termed 'postsegregational killing' (PSK) (Ogura & Hiraga, 1983; Faridani et al., 2006) . By this way, the bacteria that contain the TA loci on plasmid (commonly these plasmids also harbored the antibiotic resistant genes) will survive and the bacteria without plasmid containing TA loci and antibiotic resistant genes will be killed. Antisense therapy, which is sequence dependent, silences a specific gene. The antisense components are analogs of mRNA; therefore, this technology is involved in the inhibition of gene expression. Many techniques are available for antisense therapy that use different RNA analogs, such as phosphorodiamidate morpholino oligomers (PMOs), locked nucleic acids (LNAs) and peptide nucleic acids (PNA). Among these, the properties of PNAs make it particularly appropriate for antisense therapy in bacteria. This technique is applied for molecular bioengineering, therapeutic methods and antibiotics (Lee & Roth, 2003; Janson & Duringm 2006; Rasmussen et al., 2007) . The structure of PNAs is similar to that of DNA or RNA, except that the nucleobases are changed to a pseudopeptide (Nielsen et al., 1991) following the Watson and Crick base-pairing rule; however, PNAs can bind DNA and RNA (Jensen et al., 1997) . (Drews, 1996) . Toxin antitoxin system could be a potent target for antibiotic therapy. In theory, the activation of a toxin or inhibition of an antitoxin is an attractive strategy for antimicrobial therapy (DeNap & Hergenrother, 2005; Engelberg-Kulka et al., 2004) . Amita and colleagues demonstrated that 5% of bacterial cells were viable and 95% were killed after toxin activation because the increased toxin could not be neutralized by the antitoxin. However, when co-expressing mazE (antitoxin) and neutralizing mazF (toxin), 85% of the cells were viable because the toxin was neutralized and inhibited by the antitoxin . Hence, artificial disruption of antitoxin can lead to bacterial cell killing. However, the most important step for potency of TA system, as an antibacterial target, is to identify a TA system that is prevalent in all resistant clinical strains and determine its functionality. While the analysis of TA system can be instructive, until now, there is no information on the prevalence and identity of TA systems in a large panel of S. aureus clinical isolates. Therefore, it is necessary to study a TA system that is prevalent and transcribed in all clinical antibiotic resistant S. aureus and evaluate this target for antimicrobial therapy.
Statement of objectives

General objective
To evaluate the antitoxin (MazE) as an attractive antimicrobial target for the eradication of antibiotic resistant S. aureus.
3. 2 Specific objectives 1.
To determine the prevalence of different TA systems, their location on plasmid or chromosome and the dominant TA system in clinical isolates of antibiotic resistant S. aureus. To evaluate functionality of TA system in all clinical isolates of antibiotic resistant S. aureus.
3.
To evaluate effect of MazF toxin against antibiotic resistant S. aureus.
Statement of hypothesis
Based upon these data, it hypothesized that the identification of a dominant TA system in antibiotic resistant S. aureus will provide a novel antibacterial target against S. aureus infections. 
